12 Month Price Forecast For CRON
Distance to CRON Price Forecasts
CRON Price Momentum
๐ค Considering Cronos Group (CRON)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 15, 2025 1:01 PM UTC
CRON Analyst Ratings & Price Targets
Based on our analysis of 8 Wall Street analysts, CRON has a neutral consensus with a median price target of $2.05 (ranging from $1.97 to $2.13). Currently trading at $1.97, the median forecast implies a 4.1% upside. This outlook is supported by 2 Buy, 2 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CRON Analyst Consensus
CRON Price Target Range
Latest CRON Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CRON.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
May 15, 2024 | CIBC | John Zamparo | Outperformer | Maintains | $3.50 |
Apr 8, 2024 | B of A Securities | Lisa Lewandowski | Underperform | Maintains | $2.50 |
Dec 28, 2023 | B of A Securities | Lisa Lewandowski | Underperform | Maintains | $2.00 |
May 15, 2023 | Barclays | Gaurav Jain | Equal-Weight | Maintains | $3.00 |
Nov 2, 2022 | Bernstein | Nadine Sarwat | Market Perform | Initiates | $3.00 |
Sep 30, 2022 | Barclays | Gaurav Jain | Equal-Weight | Maintains | $3.50 |
Mar 22, 2022 | Barclays | Gaurav Jain | Equal-Weight | Upgrade | $0.00 |
Mar 7, 2022 | Piper Sandler | Michael Lavery | Neutral | Maintains | $3.00 |
Feb 22, 2022 | Canaccord Genuity | Matt Bottomley | Sell | Maintains | $4.25 |
Feb 22, 2022 | Piper Sandler | Michael Lavery | Neutral | Maintains | $4.00 |
Jan 27, 2022 | Jefferies | Owen Bennett | Hold | Upgrade | $3.24 |
Nov 18, 2021 | Barclays | Underweight | Initiates | $0.00 | |
Apr 14, 2020 | Piper Sandler | Neutral | Downgrade | $0.00 | |
Mar 31, 2020 | Canaccord Genuity | Sell | Downgrade | $0.00 | |
Nov 13, 2019 | Bank of America | Buy | Maintains | $0.00 | |
Nov 13, 2019 | B of A Securities | Buy | Maintains | $15.00 | |
Oct 22, 2019 | Piper Jaffray | Overweight | Maintains | $0.00 | |
Oct 22, 2019 | Piper Sandler | Overweight | Maintains | $12.00 | |
Aug 13, 2019 | Piper Sandler | Overweight | Initiates | $0.00 | |
Aug 13, 2019 | Piper Jaffray | Overweight | Initiates | $0.00 |
Stocks Similar to Cronos Group Inc
The following stocks are similar to Cronos Group based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Cronos Group Inc (CRON) Financial Data
Cronos Group Inc has a market capitalization of $754.12M with a P/E ratio of -10.4x. The company generates $111.23M in trailing twelve-month revenue with a -42.7% profit margin.
Revenue growth is +38.1% quarter-over-quarter, while maintaining an operating margin of -34.5% and return on equity of -4.4%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

Cronos Group Inc (CRON) Company Overview
About Cronos Group Inc
Cannabinoid company producing various cannabis products.
Cronos Group Inc. operates by cultivating, producing, and marketing a diverse range of cannabis products. The company generates revenue through the sale of its products, which include dried flower, pre-rolls, oils, vaporizers, edibles, and tinctures, marketed under well-known brands such as Spinach, Lord Jones, and PEACE NATURALS.
Founded in 2012 and headquartered in Toronto, Canada, Cronos Group Inc. has expanded its operations internationally, including markets in Israel and Germany, positioning itself in the growing global cannabis industry.
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
356
CEO
Mr. Michael Ryan Gorenstein J.D.
Country
Canada
IPO Year
2018
Website
www.thecronosgroup.comCronos Group Inc (CRON) Latest News & Analysis
Cannabis stocks are influenced by speculation regarding potential federal reforms related to marijuana legislation.
Federal reforms can significantly impact cannabis stock valuations, influencing market sentiment and investment strategies based on regulatory changes and growth prospects.
Investors in marijuana stocks face uncertainty due to the lack of federal reform in the U.S., despite state-level legalization creating legal markets for cannabis production.
Uncertainty in federal cannabis reform affects investor confidence in marijuana stocks, as state-level legalization does not guarantee stability for legal operators.
The U.S. cannabis market, exceeding $25 billion in 2021, is projected to reach $50 billion by 2026 due to legalization efforts. Canadian companies like Aurora, Cronos, and Sundial are focusing on U.S. expansion.
The cannabis industry's rapid growth and potential U.S. market access create opportunities for high returns. Legislative changes and Canadian companies' strategies enhance investment prospects.
Marijuana stock investors are optimistic for 2025, citing increased demand and rising profits among companies, despite volatility in trading. The sector shows potential for profitability.
Rising demand and record profits in the cannabis sector suggest growth potential, attracting interest despite volatility, indicating possible investment opportunities for 2025.
Cannabis stock investors face significant losses in 2023 but are hopeful for a recovery in 2025 as the U.S. legal marijuana market evolves.
Cannabis stocks are underperforming, impacting investor sentiment. A potential recovery in 2025 could signal new opportunities and shifts in market dynamics for the sector.
The cannabis industry is evolving, with U.S. market projected to surpass $40 billion by 2025. Canadian stocks may benefit from federal reform and established infrastructure. Investors should track key stocks.
Rapid evolution in the cannabis industry, especially in Canada, signals potential growth as U.S. market expansion and bipartisan support for legalization could drive stock performance.
Frequently Asked Questions About CRON Stock
What is Cronos Group Inc's (CRON) stock forecast for 2025?
Based on our analysis of 8 Wall Street analysts, Cronos Group Inc (CRON) has a median price target of $2.05. The highest price target is $2.13 and the lowest is $1.97.
Is CRON stock a good investment in 2025?
According to current analyst ratings, CRON has 2 Buy ratings, 2 Hold ratings, and 1 Sell ratings. The stock is currently trading at $1.97. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for CRON stock?
Wall Street analysts predict CRON stock could reach $2.05 in the next 12 months. This represents a 4.1% increase from the current price of $1.97. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Cronos Group Inc's business model?
Cronos Group Inc. operates by cultivating, producing, and marketing a diverse range of cannabis products. The company generates revenue through the sale of its products, which include dried flower, pre-rolls, oils, vaporizers, edibles, and tinctures, marketed under well-known brands such as Spinach, Lord Jones, and PEACE NATURALS.
What is the highest forecasted price for CRON Cronos Group Inc?
The highest price target for CRON is $2.13 from at , which represents a 8.2% increase from the current price of $1.97.
What is the lowest forecasted price for CRON Cronos Group Inc?
The lowest price target for CRON is $1.97 from at , which represents a 0.0% increase from the current price of $1.97.
What is the overall CRON consensus from analysts for Cronos Group Inc?
The overall analyst consensus for CRON is neutral. Out of 8 Wall Street analysts, 2 rate it as Buy, 2 as Hold, and 1 as Sell, with a median price target of $2.05.
How accurate are CRON stock price projections?
Stock price projections, including those for Cronos Group Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.